(Q45951142)

18 December 2017

title

Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. (English)

1 reference

18 December 2017

1 reference

1 reference

1 reference

1 reference

Bethany A DiPaula

1

1 reference

18 December 2017

Michele D Thomas

series ordinal

2

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

18 December 2017

published in

Pharmacotherapy

1 reference

18 December 2017

volume

29

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

852-857

1 reference

18 December 2017

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Nicotinic acetylcholine receptors as targets for antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Varenicline efficacy and tolerability in a subject with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Exacerbation of recurrent depression as a result of treatment with varenicline

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

Hypomania with agitation associated with varenicline use in bipolar II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.852

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.7.852

1 reference

18 December 2017

1 reference

18 December 2017